Related references
Note: Only part of the references are listed.Murine mesothelin: characterization, expression, and inhibition of tumor growth in a murine model of pancreatic cancer
Emmanuel Zervos et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway
Lirong Zhang et al.
PLOS ONE (2016)
CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
Shannon L. Maude et al.
BLOOD (2015)
Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells
Zeguo Zhao et al.
CANCER CELL (2015)
Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy
Keishi Adachi et al.
CANCER SCIENCE (2015)
CCL21-CCR7 promotes the lymph node metastasis of esophageal squamous cell carcinoma by up-regulating MUC1
Mo Shi et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Fibroblastic Reticular Cells: Organization and Regulation of the T Lymphocyte Life Cycle
Flavian D. Brown et al.
JOURNAL OF IMMUNOLOGY (2015)
Cancer immunotherapy utilizing gene-modified T cells: From the bench to the clinic
Connie P. M. Duong et al.
MOLECULAR IMMUNOLOGY (2015)
Adoptive cell transfer as personalized immunotherapy for human cancer
Steven A. Rosenberg et al.
SCIENCE (2015)
Engineering CAR-T cells: Design concepts
Shivani Srivastava et al.
TRENDS IN IMMUNOLOGY (2015)
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
Elena Sotillo et al.
CANCER DISCOVERY (2015)
Improving the safety of cell therapy with the TK-suicide gene
Raffaella Greco et al.
FRONTIERS IN PHARMACOLOGY (2015)
Type 1 interferon-induced IL-7 maintains CD8+ T-cell responses and homeostasis by suppressing PD-1 expression in viral hepatitis
Lifei Hou et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Novel activating mutations lacking cysteine in type I cytokine receptors in acute lymphoblastic leukemia
Chen Shochat et al.
BLOOD (2014)
CAR T Cells for Solid Tumors Armed and Ready to Go?
Sunitha Kakarla et al.
CANCER JOURNAL (2014)
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results
Brian G. Till et al.
BLOOD (2012)
Redirecting Gene-Modified T Cells toward Various Cancer Types Using Tagged Antibodies
Koji Tamada et al.
CLINICAL CANCER RESEARCH (2012)
IL-7 Abrogates Suppressive Activity of Human CD4+CD25+ FOXP3+ Regulatory T Cells and Allows Expansion of Alloreactive and Autoreactive T Cells
Anne-Kristin Heninger et al.
JOURNAL OF IMMUNOLOGY (2012)
Protein L: a novel reagent for the detection of Chimeric Antigen Receptor (CAR) expression by flow cytometry
Zhili Zheng et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells
Cristina Penaranda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
IL-7 Engages Multiple Mechanisms to Overcome Chronic Viral Infection and Limit Organ Pathology
Marc Pellegrini et al.
CELL (2011)
Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias
Chen Shochat et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia
Priscila P. Zenatti et al.
NATURE GENETICS (2011)
Use of the 2A Peptide for Generation of Multi-Transgenic Pigs through a Single Round of Nuclear Transfer
Wei Deng et al.
PLOS ONE (2011)
High Cleavage Efficiency of a 2A Peptide Derived from Porcine Teschovirus-1 in Human Cell Lines, Zebrafish and Mice
Jin Hee Kim et al.
PLOS ONE (2011)
Amplifying TLR-MyD88 Signals within Tumor-Specific T Cells Enhances Antitumor Activity to Suboptimal Levels of Weakly Immunogenic Tumor Antigens
Degui Geng et al.
CANCER RESEARCH (2010)
Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell-mediated Tumor Eradication
Xiao-Song Zhong et al.
MOLECULAR THERAPY (2010)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
Laura A. Johnson et al.
BLOOD (2009)
Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies
Marc Pellegrini et al.
NATURE MEDICINE (2009)
Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells
Alexander Link et al.
NATURE IMMUNOLOGY (2007)
Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration
Laura Bracci et al.
CLINICAL CANCER RESEARCH (2007)
Cell biology of IL-7, a key lymphotrophin
Q Jiang et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
IL-7: maintaining T-cell memory and achieving homeostasis
LM Bradley et al.
TRENDS IN IMMUNOLOGY (2005)
Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis
SA Luther et al.
JOURNAL OF IMMUNOLOGY (2002)
Interleukin-7: master regulator of peripheral T-cell homeostasis?
TJ Fry et al.
TRENDS IN IMMUNOLOGY (2001)
Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse
SA Luther et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Suicide genes: past, present and future perspectives
S Lal et al.
IMMUNOLOGY TODAY (2000)
Share Paper
